

Massie_Lab
104 posts

@Massie_Lab
Using genetic and epigenetic alterations found in early stage cancers we develop novel assays to help detect aggressive cancers at an early and treatable stage



We are delighted to announce the second in our new seminar series - @afilimon on Somatic evolution during ageing and carcinogenesis. 📅 Thursday 8th December, 12.30-14:00 including lunch! Clifford Allbutt Lecture theatre, CB2 0AH 👉Register here: earlycancer.cam.ac.uk/events/early-c…

.@CR_UK CEO, @Michelle_CRUK congratulates Rebecca Fitzgerald, the winner of our Impact Recognition Award, for her outstanding contribution to #oncology and her determination to drive forward the translation & commercialisation of her discoveries for patient benefit. #IEAwards22

.@CR_UK CEO, @Michelle_CRUK congratulates Rebecca Fitzgerald, the winner of our Impact Recognition Award, for her outstanding contribution to #oncology and her determination to drive forward the translation & commercialisation of her discoveries for patient benefit. #IEAwards22

Although Renal Cell Cancer (RCC) is one of the most common cancers worldwide, existing diagnostic strategies are unable to accurately differentiate malignant from benign small renal masses preoperatively. This results in 20% of patients undergoing unnecessary surgery. 2/10
















Register now to hear Dr Jeremy Clark's talk, 'The PUR (Prostate Urine Risk) biomarker for prostate cancer detection and prognosis', on 18 November 2021 at 4.30pm at the CRUK Cambridge Institute Lecture Theatre! Register here: eventbrite.co.uk/e/194594747127